Fulgent Genetics, Inc.
FLGT
Revenue
71.03M
▲6.54M▲10.15%
3 Months ChangeAssets
1.23B
▲2.35M▲0.1914%
3 Months ChangeLiabilities
103.39M
▲152.00k▲0.1472%
3 Months ChangeFree Cash Flow
3.21M
▲13.15M▲132.29%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-02
Form 10-Q
ID: 0000950170-24-089592
2024-08-02
Form 8-K
ID: 0000950170-24-089587
2024-05-16
Form 8-K
ID: 0000950170-24-061120
2024-05-03
Form 10-Q
ID: 0000950170-24-052485
2024-05-03
Form 8-K
ID: 0000950170-24-052481
2024-02-28
Form 8-K
ID: 0000950170-24-021645
2023-11-03
Form 10-Q
ID: 0000950170-23-058512
2023-11-03
Form 8-K
ID: 0000950170-23-058509
2023-08-04
Form 10-Q
ID: 0000950170-23-038316
2023-08-04
Form 8-K
ID: 0000950170-23-038312